EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells

Md Moniruzzaman iD, M Arifur Rahman iD, Ran Wang iD, Kuan Yau Wong iD, Alice C-H Chen iD, Alexandra Mueller iD, Steven Taylor iD, Alexa Harding iD, Thishan Illankoon iD, Percival Wiid iD, Haressh Sajiir iD, Veronika Schreiber iD und 4 weitere

Journal of Experimental Medicine · 06.11.2023 · 220 (11)

DOI: 10.1084/jem.20230106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 11.09.2023. Verfasst von Md Moniruzzaman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, The University of Queensland , Brisbane, Australia. Hauptthemen laut MEDLINE: Major Histocompatibility Complex, Interleukins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Translational Research Institute, QIMR Berghofer Medical Research Institute, Australian Government Department of Education and Training.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major histocompatibility complex (MHC) II is dynamically expressed on mucosal epithelial cells and is induced in response to inflammation and parasitic infections, upon exposure to microbiota, and is increased in chronic inflammatory diseases. However, the regulation of epithelial cell–specific MHC II during homeostasis is yet to be explored. We discovered a novel role for IL-22 in suppressing epithelial cell MHC II partially via the regulation of endoplasmic reticulum (ER) stress, using animals lacking the interleukin-22-receptor (IL-22RA1), primary human and murine intestinal and respiratory organoids, and murine models of respiratory virus infection or with intestinal epithelial cell defects. IL-22 directly downregulated interferon-γ–induced MHC II on primary epithelial cells by modulating the expression of MHC II antigen A α (H2-Aα) and Class II transactivator (Ciita), a master regulator of MHC II gene expression. IL-22RA1-knockouts have significantly higher MHC II expression on mucosal epithelial cells. Thus, while IL-22–based therapeutics improve pathology in chronic disease, their use may increase susceptibility to viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Histocompatibility ComplexInterleukinsHumansAnimalsMiceEndoplasmic Reticulum StressEpithelial CellsInterleukin-22

Substanzen

InterleukinsInterleukin-22

Autor:innen und Institutionen

  • Faculty of Medicine, The University of Queensland , Brisbane, Australia.
  • Immunopathology Group, Translational Research Institute, Mater Research Institute-The University of Queensland , Brisbane, Australia.
  • South Australian Health and Medical Research Institute , Adelaide, Australia.
  • Department of Respiratory and Sleep Medicine, Mater Health, South Brisbane, Australia.
  • Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne , Parkville, Australia.
  • Australian Infectious Diseases Research Centre, The University of Queensland , Brisbane, Australia.

ORCID-Profile: Md Moniruzzaman, M Arifur Rahman, Ran Wang, Kuan Yau Wong, Alice C-H Chen, Alexandra Mueller, Steven Taylor, Alexa Harding, Thishan Illankoon, Percival Wiid, Haressh Sajiir, Veronika Schreiber, Lucy D Burr, Michael A McGuckin, Simon Phipps, Sumaira Z Hasnain

Förderung

  • Translational Research Institute
  • QIMR Berghofer Medical Research Institute
  • Australian Government Department of Education and Training
  • University of Queensland
  • Mater Research
  • Gastroenterological Society of Australia
  • National Health and Medical Research Council
  • Australian Infectious Diseases Research Centre

Zitieren

APA

Moniruzzaman, M., Rahman, M. A., Wang, R., Wong, K. Y., Chen, A. C., Mueller, A., Taylor, S., Harding, A., Illankoon, T., Wiid, P., Sajiir, H., Schreiber, V., Burr, L. D., McGuckin, M. A., Phipps, S., & Hasnain, S. Z. (2023). Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells. Journal of Experimental Medicine, 220(11). https://doi.org/10.1084/jem.20230106

Vancouver

Moniruzzaman M, Rahman MA, Wang R, Wong KY, Chen AC, Mueller A, et al. Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells. Journal of Experimental Medicine. 2023;220(11). doi:10.1084/jem.20230106

BibTeX
@article{Moniruzzaman2023,
  author = {Moniruzzaman, Md and Rahman, M Arifur and Wang, Ran and Wong, Kuan Yau and Chen, Alice C-H and Mueller, Alexandra and Taylor, Steven and Harding, Alexa and Illankoon, Thishan and Wiid, Percival and Sajiir, Haressh and Schreiber, Veronika and Burr, Lucy D and McGuckin, Michael A and Phipps, Simon and Hasnain, Sumaira Z},
  title = {Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells},
  journal = {Journal of Experimental Medicine},
  year = {2023},
  volume = {220},
  number = {11},
  doi = {10.1084/jem.20230106}
}
Kostenlos starten →